Postoperative USG Control and Clinical Follow-up of Massive Rotator Cuff Tendon Ruptures
NCT ID: NCT07004218
Last Updated: 2025-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
40 participants
OBSERVATIONAL
2025-02-01
2026-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary outcome is the rate and timing of retears at 12 months and their correlation with functional recovery. The study also aims to identify prognostic factors affecting tendon survivability, such as age, tear size, and muscle quality. By combining imaging and clinical parameters, this study seeks to contribute to the optimization of postoperative follow-up and rehabilitation strategies in the treatment of massive rotator cuff tears.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Results of Arthroscopic-Assisted Lower Trapezius Tendon Transfer for Massive, Irreparable Rotator Cuff Tears
NCT06258278
Effectiveness of The Neuromuscular Control-Based Exercise Training in the Treatment of Partial-Thickness Rotator Cuff Tears
NCT05128474
Subscapularis Tears in Large to Massive Rotator Cuff Tear
NCT03352180
Acute Effects of Fascial Release Technique in Patients With Rotator Cuff Repair
NCT05176028
The Effect of Microfracture Procedure on Rotator Cuff Tendon Healing
NCT04421417
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Massive tears are defined as full-thickness tears involving two or more rotator cuff tendons and/or showing retraction to the level of the glenoid. Exclusion criteria include irreparable tears, prior shoulder surgery on the affected side, severe glenohumeral arthritis, neurological deficits affecting shoulder function, systemic inflammatory diseases, and inability to comply with follow-up.
Ultrasonographic evaluations of tendon integrity will be performed postoperatively at 2 weeks, 3 months, 6 months, and 12 months. These will be conducted by a radiologist in collaboration with orthopedic residents. Tendon status will be categorized as intact, partial retear, or complete retear. Clinical outcomes will be measured using the American Shoulder and Elbow Surgeons (ASES) Score, the UCLA Shoulder Score, the Visual Analog Scale (VAS), and evaluated in terms of Minimal Clinically Important Difference (MCID), Substantial Clinical Benefit (SCB), and Patient Acceptable Symptom State (PASS).
The primary endpoint is the rate of retear at 12 months and its association with clinical recovery. This study aims to clarify the relationship between early tendon healing and long-term functional outcomes, potentially guiding future management strategies in massive rotator cuff repair.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Scheduled for surgical rotator cuff repair at Gazi University Hospital, Department of Orthopaedics and Traumatology.
Ability and willingness to undergo postoperative follow-up and imaging (ultrasound) at 2 weeks, 3 months, 6 months, and 12 months post-surgery.
Ability to provide written informed consent.
No prior surgery on the affected shoulder.
Adequate cognitive and physical capacity to comply with postoperative rehabilitation protocols and outcome assessments.
Exclusion Criteria
Irreparable rotator cuff tears determined intraoperatively (e.g., excessive retraction, poor tissue quality).
Presence of advanced glenohumeral osteoarthritis (e.g., Hamada grade ≥ 3).
Neurological disorders affecting shoulder function (e.g., brachial plexopathy, stroke-related hemiparesis).
Systemic inflammatory or rheumatologic diseases (e.g., rheumatoid arthritis, lupus) affecting musculoskeletal function.
Infectious conditions of the shoulder or systemic infection at the time of surgery.
Inability to attend regular follow-ups or comply with the rehabilitation protocol due to psychiatric illness, cognitive impairment, or other medical conditions.
Refusal or inability to provide informed consent.
Poor general health status contraindicating surgery or anesthesia (e.g., ASA IV or higher
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gazi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Furkan ARAL
STUDY_CHAİR GAZİ UNİVERSİTY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gazı University
Çankaya, Ankara, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-77082166-604.01-1134735
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.